Close Menu

NEW YORK – Quidel reported after the close of the market on Wednesday that its third quarter revenues rose 8 percent year over year, beating Wall Street estimates.

For the three months ended Sept. 30, revenues increased to $126.5 million from $117.4 million in Q3 2018, beating the average analyst expectation of $125.6 million. The increase was driven primarily by growth in the rapid immunoassay business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.

By Biotech Support Group LLC